SCHEMBL29641652

SCHEMBL29641652

CC(O)c1oc(=O)c2ccccc2c1-c1cccc(CN(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPT P10636 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MAOB P27338 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ TP53 P04637 2/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ ACHE P22303 4/20 0.37
▸ TLR8 Q9NR97 2/20 0.37
▸ TLR7 Q9NYK1 2/20 0.37
▸ TLR9 Q9NR96 1/20 0.37
▸ NMT1 P30419 1/20 0.36
▸ PTGES O14684 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ AOC3 Q16853 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22504992 1.00 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNAMAPTNPSR1
SCHEMBL29641495 0.88 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2LMNAMAPTNPSR1
SCHEMBL22504987 0.88 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2LMNAMAPTNPSR1
SCHEMBL16783614 0.82 TP53 (0.45) ALDH1A1SMN1; SMN2LMNAL3MBTL1TP53
SCHEMBL16783421 0.81 MEN1 (0.45) ALDH1A1DRD2ACHETLR8TLR7
SCHEMBL16783613 0.80 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2LMNAMAPTL3MBTL1
SCHEMBL22498062 0.80 ACHE (0.52) ALDH1A1SMN1; SMN2LMNATP53ACHE
SCHEMBL30679717 0.80 ACHE (0.52) ALDH1A1SMN1; SMN2LMNATP53ACHE
SCHEMBL16783528 0.79 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNANPSR1L3MBTL1
SCHEMBL16783749 0.79 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2LMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12527797-B2 Isochromene derivatives as phosphoinositide 3-kinases inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2026-01-20 — — US disclosed
US-20220175784-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220175784-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS PIKFYVE, PDPK1, PIK3R5 ALDH1A1 3562/4885SMN1; SMN2 2951/4885LMNA 4307/4885
US-12527797-B2 Isochromene derivatives as phosphoinositide 3-kinases inhibitors PIK3R5, PIK3CD, PIK3R4 ALDH1A1 3567/4885SMN1; SMN2 4264/4885LMNA 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback